Eli Lilly’s late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results.

More than 5.8 million people are living with diabetes in the UK, and nine in 10 have type 2. This type occurs when the ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...

Medications for type 2 diabetes address different aspects of blood sugar management and are tailored to individual health needs. Navigating type 2 diabetes treatment options can be complex, but ...

Learn why GLP-1 use isn’t included in how experts define type 2 diabetes remission despite the drugs’ ability to help manage blood sugar and reduce a person’s A1C.

Type 2 diabetes care has entered a smarter, more personal era — where technology, medicine, and lifestyle all work together. Continuous glucose monitors now give people real-time feedback on how meals ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

NORTH PHILADELPHIA (WPVI) -- Cases of type 2 diabetes are increasing so quickly that the CDC predicts 40% of Americans and more than half of all African-Americans and Latinos will develop it in their ...

Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...

A surprising new clinical trial has revealed that metformin—a cheap, century-old drug widely used for type 2 diabetes—may help people with type 1 diabetes in an unexpected way. While researchers ...